Skip to main content

Find Clinical Trials

Clinical trial condition

NSCLC

Explore clinical trials studying NSCLC. Study availability and eligibility vary by location and protocol.

367 public trials 125 recruiting studies

Refine in advanced search Browse all conditions

NSCLC trial results

Completed

EBUS-Miniforceps Biopsy Specimen Acquisition for PD-L1 Testing in Nonsmall Cell Lung Cancer

NCT04159025

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Efficacy and Safety Analysis of ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced NSCLC in Elderly Patients

NCT05688046

Conditions: NSCLC
Locations: The Affiliated Suzhou Hospital of Nanjing Medical University Suzhou, Jiangsu, China

View Trial Details

Completed

A Real-world Study: Efficacy and Safety of Anlotinib for Advanced Non-small Cell Lung Cancer(NSCLC)

NCT04871997

Conditions: NSCLC
Locations: Hubei province Wuhan, Hubei, China

View Trial Details

Completed

Phase 1/2 Study of Ensartinib and Durvalumab, in ALK-rearranged Non-small Cell Lung Cancer

NCT02898116

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +12 more
Locations: Research Facility New York, United States

View Trial Details

Completed

Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC

NCT03164772

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Research Facility Gilbert, Arizona, United States

Research Facility Tampa, Florida, United States

Research Facility Detroit, Michigan, United States

Research Facility New York, United States

View Trial Details

Completed

A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors

NCT03965845

Conditions: CRC, KRAS Gene Mutation, NSCLC, +1 more
Locations: UCLA Hematology/Oncology Santa Monica, California, United States

Emory, Winship Cancer Institute Atlanta, Georgia, United States

Northwestern University Feinberg School of Medicine Chicago, Illinois, United States

Rush University Medical Center Chicago, Illinois, United States

View Trial Details

Completed

Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor

NCT04545632

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +37 more
Locations: Hanyang University Guri Hospital Guri-si, South Korea

View Trial Details

Completed

To Evaluate the Comparative Pharmacokinetics of Orally Administered EQ143 in Different Racial and Ethnic Populations

NCT04969965

Conditions: Healthy Volunteers, NSCLC, Pharmacokinetics
Locations: Spaulding Clinical Research West Bend, Wisconsin, United States

New Zealand Clinical Research Auckland, New Zealand

View Trial Details

Completed

Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies

NCT02648724

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: University of Colorado Cancer Center Aurora, Colorado, United States

University of Chicago Medical Center Chicago, Illinois, United States

Indiana University Health Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View all 27 locations

View Trial Details

Completed

EUCROSS: European Trial on Crizotinib in ROS1 Translocated Lung Cancer

NCT02183870

Conditions: Adenocarcinoma, Carcinoma, Lung Cancer, +10 more
Locations: Thoraxklinik Heidelberg Heidelberg, Baden-Würtemberg, Germany

Universitätsklinikum Frankfurt - Medizinische Klinik II Frankfurt a.M., Hesse, Germany

LungenClinic Großhansdorf Großhansdorf, Schleswig-Holstein, Germany

Evangelische Lungenklinik Berlin Berlin, Germany

View all 18 locations

View Trial Details